LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on PYXS stock, giving a Buy rating on November 7. Sam Slutsky’s ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results ...

Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a GMP ...

With that, please advance to the next slide and I'll hand over to Susan to cover key R&D highlights from the quarter ... World Congress on Lung Cancer and the European Society for Medical Oncology ...

This analysis covers funding - public and private ... as well as expanding applications beyond oncology. Innovations in the biopsy devices industry focus on advancing technologies, with breakthroughs ...

Increasing concerns over clinicians' risks of developing cancer or other health problems from ionizing radiation exposures on ...

Thank you for standing by. My name is John, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Assertio Holdings third-quarter results conference call.

LOUISVILLE, Ky. -- Large tumor size and high disease grade were associated with an increased risk of early cancer-related ...

"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

Four years of medical school, three years of residency, and two to four years of fellowship for adult, pediatric ...

This agreement will initially cover three vehicle models ... at the Connective Tissue Oncology Society (#CTOS2024) 2024 Annual Meeting. TURALIO is the first and only oral... at 08:05 Medidata Unveils ...

A new retrospective study published in the Frontiers in Neurology highlighted the relationship between mean fasting blood ...